Back to results
US 2021/0196652 A1Published application
Use of cysteamine and derivatives thereof to treat dysfunctional tear syndrome (dts)
AssigneeMeshaberase, LLC
InventorBenjamin RUBIN
Life of this patent
Estimating the term…
Abstract
Methods for treating or inhibiting dysfunctional tear syndrome (DTS) or symptoms associated therewith, and compositions for use in the methods.
Claims11
A method for reducing at least one symptom of dysfunctional tear syndrome (DTS) or ocular lubrication dysfunction comprising administering cysteamine, or a derivative thereof, to a subject exhibiting at least one symptom of DTS or ocular lubrication dysfunction.
Dependencies are inferred from the claim text.